Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT201 vs zopiclone for insomnia disorder
CTR20221287Phase 3Completed
- Sponsor
- Jingxin Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimdazenil in Insomnia, sponsored by Jingxin Pharmaceutical. Started May 2022; status: completed.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20221287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20221287.